Axsome Therapeutics, Inc. (AXSM)
207.00
+1.52
(+0.74%)
USD |
NASDAQ |
Aug 26, 16:00
207.00
0.00 (0.00%)
After-Hours: 20:00
Axsome Therapeutics Price to Book Value : 129.96 for Aug. 26, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 129.00 |
| August 24, 2026 | 128.95 |
| August 21, 2026 | 130.44 |
| August 20, 2026 | 130.61 |
| August 19, 2026 | 136.99 |
| August 18, 2026 | 135.41 |
| August 17, 2026 | 135.78 |
| August 14, 2026 | 134.15 |
| August 13, 2026 | 134.15 |
| August 12, 2026 | 134.77 |
| August 11, 2026 | 135.46 |
| August 10, 2026 | 138.68 |
| August 07, 2026 | 133.56 |
| August 06, 2026 | 131.92 |
| August 05, 2026 | 133.63 |
| August 04, 2026 | 133.20 |
| August 03, 2026 | 132.50 |
| July 31, 2026 | 136.86 |
| July 30, 2026 | 147.31 |
| July 29, 2026 | 142.78 |
| July 28, 2026 | 147.04 |
| July 27, 2026 | 149.65 |
| July 24, 2026 | 151.30 |
| July 23, 2026 | 151.64 |
| July 22, 2026 | 150.44 |
| Date | Value |
|---|---|
| July 21, 2026 | 148.76 |
| July 20, 2026 | 139.15 |
| July 17, 2026 | 144.40 |
| July 16, 2026 | 148.82 |
| July 15, 2026 | 149.13 |
| July 14, 2026 | 147.70 |
| July 13, 2026 | 143.32 |
| July 10, 2026 | 146.78 |
| July 09, 2026 | 156.30 |
| July 08, 2026 | 154.17 |
| July 07, 2026 | 156.80 |
| July 06, 2026 | 152.31 |
| July 02, 2026 | 153.38 |
| July 01, 2026 | 151.09 |
| June 30, 2026 | 153.67 |
| June 29, 2026 | 227.13 |
| June 26, 2026 | 227.65 |
| June 25, 2026 | 223.56 |
| June 24, 2026 | 224.12 |
| June 23, 2026 | 227.93 |
| June 22, 2026 | 233.47 |
| June 18, 2026 | 235.97 |
| June 17, 2026 | 237.53 |
| June 16, 2026 | 237.30 |
| June 15, 2026 | 238.70 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 33.02 |
| Liquidia Corp. | 32.58 |
| Filana Therapeutics, Inc. | 0.6987 |
| CorMedix, Inc. | 1.412 |
| Eloxx Pharmaceuticals, Inc. | 1.584 |
Price to Book Value Related Metrics
| PS Ratio | 13.57 |
| Price | 207.00 |
| Earnings Yield | -1.82% |
| Market Cap | 10.83B |